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ABSTRACT
Skin lesions are commonly benign in nature. The present study aims to evaluate the prevalence and clinicopathological 
characteristics of a large series of benign skin lesions (BSLs) excised in our clinic. Patients with skin lesions who 
underwent total excisional biopsy at the general surgery clinic between 2012 and 2016 were reviewed. A total of 551 
patients with BSLs were included in the study. Of these, 43.7% were females and 56.7% were males. The age range was 
between 2 and 98 years with a mean of 39.7 years. The most commonly occurring group of BSLs was of the appendageal 
tumors (33.3%), and this finding was statistically significant. The most common keratinocytic BSL (13.6%) was verruca 
vulgaris. In the present study, various types of BSLs and their occurrences were evaluated. Benign skin tumors can turn 
into malignant types. A biopsy should be performed to establish the exact diagnosis. We performed an excisional biopsy 
to confirm the diagnosis.
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ABSTRAK
Lesi kulit adalah perkara biasa dan kebanyakannya lesi jinak. Tujuan kajian ini adalah untuk menilai kelaziman dan 
ciri klinikopatologi siri besar lesi kulit benigna yang dikeluarkan di klinik kami. Pesakit yang mengalami lesi kulit dikaji 
semula, yang menjalani jumlah biopsi ekslusif dalam klinik pembedahan umum antara 2012 dan 2016. Sejumlah 551 
pesakit dengan lesi kulit benigna termasuk dalam kajian ini. Daripada pesakit ini, 43.7% adalah wanita dan 56.7% 
adalah lelaki. Julat umur adalah antara 2 dan 98 tahun dengan purata 39.7 tahun. Kumpulan yang paling biasa (33.3%) 
lesi kulit jinak adalah tumor lampiran dan penemuan ini secara statistik secara signifikan. Lesi kulit yang paling biasa 
(13.6%) adalah verruca vulgaris. Dalam kajian ini, pelbagai jenis lesi kulit benigna dan frekuensi relatifnya dinilai. 
Tumor kulit benigna boleh berubah menjadi jenis malignan. Biopsi perlu diambil untuk menentukan diagnosis yang 
tepat. Kami melakukan biopsi pengecualian untuk diagnosis.
Kata kunci: Biopsi eksisi;  lesi kulit benigna; pemeriksaan klinikopatologi
INTRODUCTION
The vast majority of skin lesions are benign (Nguyen & 
Zuniga 2013). A benign skin lesion (BSL) does not spread 
to other parts of the body but continues its growth at 
the location of its origin (Higgins et al. 2015; Ingraffea 
2013). Premalignant skin lesions (PSLs) can transform into 
malignant tumors at a rate of 10% (Freak 2005; Ingraffea 
2013). They are most commonly seen in males (Higgins et 
al. 2015; Ingraffea 2013). The lifetime risk of skin cancer 
development has been reported in one out of five people 
in the United States (Freak 2005; Higgins et al. 2015; 
Ingraffea 2013).
 Skin lesions are usually sporadic; however, they 
can also be a symptom of a syndrome, or they may be 
associated with systemic malignancies (Ingraffea 2013; 
Nguyen & Zuniga 2013). Therefore, clinicians should 
differentiate benign from malignant lesions and should 
follow a systematic approach in evaluating these lesions 
(Gogi & Ramanujam 2013). If there is a clinical suspicion 
of malignancy, biopsy should definitely be performed 
(Woon & Serpell 2008).
 Along with the reported findings in the literature, the 
present study aims to review and evaluate the prevalence 
and clinicopathological features of the BSLs that are 
surgically excised in our clinic. Patients with skin lesions 
who underwent total excisional biopsy at the general 
surgery department between 2012 and 2016 were reviewed. 
The histopathological diagnoses of these lesions were 
examined to determine whether they were associated with 
the tumor size, location, and number and whether they were 
associated with the age and gender.
MATERIALS AND METHODS
The present study included patients with skin lesions 
treated in our general surgery clinic between 2012 and 
2016. Patients were followed up for recurrence for a mean 
period of 2 years. The patients’ charts showed that a total 
of 712 patients underwent excisional biopsy due to several 
types of skin lesions (Edlich et al. 2004). Of these, 27 
patients were diagnosed with nonspecific skin lesions and 
136 were diagnosed with malignant skin lesions (MSLs). 
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Ultrasonography, computed tomography, or magnetic 
resonance imaging was performed for patients with skin 
lesions before biopsy, depending on physical examination 
findings of the size and appearance of the lesion. Fine-
needle, tru-cut, or excisional biopsy was performed for 
diagnosis. Patients with nonspecific skin lesions and 
MSLs were excluded from the study. Of those who were 
diagnosed with a MSL through pathological examination, 
nine had been prediagnosed with BSL after the physical 
examination; however, the excisional biopsy result was 
reported to confirm malignant lesion. 
 A total of 551 patients with BSLs were included in 
the study. Patients with BSLs were evaluated. Patients 
undergoing follow-up or tru-cut biopsy, those who were 
not followed up, those without excisional biopsy, and 
those whose data were not accessible were excluded 
from the study. Patients undergoing fine-needle biopsy 
and tru-cut biopsy for the diagnosis of BLS (14 patients) 
were excluded from the study because of their small 
number. Patients undergoing excisional biopsy and those 
whose data were accessible were included in the study. 
The lesion size, number of lesions, and morphology were 
not limited.
 The age and gender of patients as well as the 
number, size in millimeter (mm), anatomical location, 
and histopathological diagnosis of the skin lesions were 
evaluated. They were categorized into 0-14, 15-59, and 
≥60 age groups based on other scientific studies (Murray 
et al. 2007). 
 In the present study, BSLs were categorized and listed 
according to the World Health Organization histological 
classification (LeBoit et al. 2006). Accordingly, they were 
categorized into six main groups and examined. These 
main groups were keratinocytic, melanocytic, appendageal, 
hematolymphoid, soft tissue, and neural BSLs. The lesions 
included in these main groups were examined (Table 1).
STATISTICAL ANALYSES
The data obtained from the present study were analyzed 
using IBM SPSS Statistics Version 22 package software. 
Shapiro-Wilk test was performed to determine normal 
TABLE 1. Benign skin lesions subtypes
Benign skin lesions Number of lesions
n %
Keratinocytic Verruca vulgaris
Verruca plantaris
Seborrheic keratosis
Keratoacanthoma
Lichen planus-like keratosis
75
29
27
5
5
53.19
20.57
19.15
3.55
3.55
Melanocytic Melanocytic nevi
Combined nevus
55
16
77.46
22.54
Appendageal Hidrocystoma
Cystic sebaceous tumor
Chondroid syringoma
Hidradenoma
Pilomatricoma
Trichoblastoma
Trichilemmoma
Sebaceoma
1
144
2
2
8
1
24
2
0.54
78.26
1.09
1.09
4.35
0.54
13.04
1.09
Hemato-lymphoid Lymphomatoid granulomatosis
Juvenile xanthogranuloma
3
2
60
40
Soft tissue Dermatofibroma
Cherry hemangioma
Pyogenic granuloma
Cavernous hemangioma
Arteriovenous hemangioma
Lymphangioma circumscriptum
Digital fibrokeratoma
Dermatomyofibroma
Lipoma
Digital mucous cyst
Keloid scar
Hypertrophic scar
33
15
19
2
3
2
4
3
41
1
17
5
22.76
10.34
13.1
1.38
2.07
1.38
2.76
2.07
28.28
0.69
11.72
3.45
Neural Neurothekeoma
Neuroma
Granular cell tumor
3
1
1
60
20
20
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distribution of the variables. In interpreting the results, 
if p value was greater than 0.05, it was considered that 
the variables came from the normal distribution; if p 
value was less than 0.05, it was considered that the 
variables did not come from the normal distribution. The 
Mann–Whitney U and Kruskal–Wallis H tests were used 
to examine the differences between the groups as the 
variables were not normally distributed. The Chi-square 
(χ²) analysis was used to analyze the associations between 
the groups of nominal variables. Fisher’s exact test was 
used when the expected values in the cells of the 2 × 2 
tables did not achieve a sufficient size. The significance 
level of 0.05 was used to interpret the results. A p value 
less than 0.05 indicated a significant association, whereas 
p values greater than 0.05 indicated that there was no 
significant association.
RESULTS 
The present study included a total of 551 patients. The 
majority of patients (56.2%, n = 310) were males, and 
the study population had a female:male ratio of 241/310 
(0.77). The age of patients in the study ranged from 2 
to 98 years, and the mean age was 39.7 years. The most 
common (18.8%, n = 104) accompanying disease group 
were hepatobiliary disorders (fatty liver and gall bladder 
stone). BSLs were most commonly located in the head and 
neck region (43.1%, n = 239). The lesions were mostly 
single (82.5%, n = 455) with a mean diameter of 14.1 
mm. The success rate of excisional biopsy diagnosis was 
100% (n = 551). The mean follow-up period was 2 years. 
The rate of local recurrence was 2.3% (n = 13) (Table 2).
 A statistically significant difference between the gender 
and the BSL groups (p = 0.001) was observed. Appendageal 
BSLs were present in 29.05% (n = 70) of females and in 
36.77% (n = 114) of males. Soft tissue BSLs were present in 
21.58% (n = 52) of females and in 30% (n = 93) of males. 
Keratinocytic BSLs were present in 26.14% (n = 63) of 
females and in 25.16% (n = 78) of males. Melanocytic BSLs 
were present in 21.58% (n = 52) of females and in 6.13% 
(n = 18) of males. Hematolymphoid BSLs were present in 
1.24% (n = 3) of females and in 0.65% (n=2) of males. 
Neural BSLs were present in 0.41% (n = 1) of females and 
in 1.29% (n = 4) of males (Table 3). 
 In the present study, a statistically significant association 
between the BSL groups and the age distribution (p = 0.008) 
was observed. In the 0–14 age group, 2.94% (n = 1) of 
patients had appendageal BSLs. This was 35.23% (n = 155) 
in the 15–59 age group, and 36.36% (n = 36) in the 60 and 
above age group. Soft tissue BSLs were present in 35.29% (n 
= 12) of patients in the 0-14 age group. Additionally, these 
types of skin lesions were present in 27.05% (n = 119) in the 
15-59 age group and in 18.18% (n = 14) in the 60 and above 
age group. Keratinocytic BSLs were present in 41.18% (n = 
14) of patients in the 0-14 age group, in 22.5% (n = 99) in 
the 15-59 age group, and in 36.36% (n = 28) in the 60 and 
above age group. Melanocytic BSLs were present in 14.71% 
(n = 5) of patients in the 0-14 age group, in 13.41% (n = 
59) in the 15-59 age group, and in 9.09% (n = 7) in the 60 
and above age group. Hematolymphoid BSLs were present 
in 2.94% (n = 1) of patients in the 0-14 age group and in 
0.91% (n = 4) in the 15-59 age group. Neural BSLs were 
present in 2.94% (n = 1) of patients in the 0-14 age group 
and in 0.91% (n = 4) in the 15-59 age group (Table 3).
TABLE 2. Demographic and clinical characteristics of subjects
Demographic and clinical features Distribution of properties
Gender (Female/Male) 241/310 (0.77)
Age 2–98 (mean 39.7) years
Age distribution 0–14 (6.1%, n = 34)
15–59 (79.8%, n = 440)
≥60 (13.9%, n = 77)
Comorbidities Hepatobiliary disease (18.8%, n = 104)
Renal disease (12.5%, n = 69)
Endocrine diseases (7%, n = 39)
Vascular disease (6.2%, n = 34)
Gynecological disease (2.3%, n = 13)
The main complaint Painless swelling (90%, n = 496)
Color change (32%, n = 176)
Lesion localization Head and neck (43.4%, n = 239)
Trunk (25.9%, n = 143)
Upper extremities (13.7%, n = 76)
Lower extremities (17.0%, n = 94)
Number of lesions Single (82.5%, n = 455)
Multiple (17.4%, n = 96)
Lesion diameter 1–70 (mean 14.1) mm
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 There was a statistically significant relationship 
between the original localization of the tumor and the BSL 
groups (p = 0.001). Appendageal BSLs comprised 36.55% 
(n = 87) of the neoplasms originating from the head and 
neck region, 48.95% (n = 70) of the neoplasms originating 
from the trunk, 26.32% (n = 20) from tumors of the upper 
extremities, and 7.45% (n = 7) from tumors of the lower 
extremities. Soft tissue BSLs comprised 15.55% (n = 37) of 
the neoplasms originating from the head and neck region, 
30.07% (n = 43) from the trunk, 47.37% (n = 36) from the 
upper extremities, and 30.85% (n = 29) from the lower 
extremities. Keratinocytic BSLs comprised 21.85% (n = 
52) of the neoplasms originating from the head and neck 
region, 18.42% (n = 20) from the trunk, 18.42% (n = 14) 
from the upper extremities, and 58.51% (n = 55) from the 
lower extremities. Melanocytic BSLs comprised 23.95% (n 
= 57) of the neoplasms originating from the head and neck 
region, 6.29% (n = 9) from the trunk, 3.95% (n = 3) from 
the upper extremities, and 2.13% (n = 2) from the lower 
extremities. Hematolymphoid BSLs comprised 0.42% (n 
= 1) of the neoplasms originating from the head and neck 
region, 0.7% (n = 1) from the trunk, and 3.95% (n = 3) 
from the upper extremities. Neural BSLs comprised 1.68% 
(n = 4) of the tumors originating from the head and neck 
region and 1.06% (n=1) of the tumors originating from the 
lower extremities (Table 3). 
 There was a statistically significant difference 
between the number of the lesions and the BSL groups (p 
= 0.001). Appendageal BSLs comprised 35.82% (n = 163) 
of the single lesions and 21.88% (n = 21) of the multiple 
lesions. Soft tissue BSLs comprised 28.13% (n = 128) of 
the single lesions and 17.71% (n = 17) of the multiple 
lesions. Keratinocytic BSLs comprised 23.3% (n = 106) 
of the single lesions and 36.46% (n = 35) of the multiple 
lesions. Melanocytic BSLs comprised 10.55% (n = 48) 
of the single lesions and 23.96% (n = 23) of the multiple 
lesions. Hematolymphoid BSLs comprised 1.1% (n = 5) of 
the single lesions. A total of 1.1% of the single lesions was 
considered as neural BSLs.
 There were statistically significant differences between 
BSL groups in terms of the diameters of the lesions (p = 
0.001). The mean diameters of the lesions were 17.33 
(n = 184) for appendageal BSLs, 15.8 mm (n = 5) for 
neural BSLs, 15.66 mm (n = 145) for soft tissue BSLs, 
11.26 mm (n = 141) for keratinocytic BSLs, 9.2 mm (n = 
5) for hematolymphoid BSLs, and 8.73 mm (n = 71) for 
TABLE 3. The relationship between gender, age, number of lesions, and localization of benign skin lesions
Benign skin lesions Gender
Chi-square TestFemale Male
n % n % p
Keratinocytic 
Melanocytic 
Appendageal
Haematolymphoid 
Soft tissue 
Neural 
63
52
70
3
52
1
26.14
21.58
29.05
1.24
21.58
0.41
78
19
114
2
93
4
25.16
6.13
36.77
0.65
30
1.29
0.001
Age groups Chi-square Test
0-14 Years 15-59 years ≥60 years 
n % n % n % p
Keratinocytic 
Melanocytic 
Appendageal 
Haematolymphoid 
Soft tissue 
Neural 
14
5
1
1
12
1
41.18
14.71
2.94
2.94
35.29
2.94
99
59
155
4
119
4
22.5
13.41
35.23
0.91
27.05
0.91
28
7
28
0
14
0
36.36
9.09
36.36
0
18.18
0
0.008
Localization Chi-square Test
Head and neck Trunk Upper extremity Lower 
extremity
n % n % n % n % p
Keratinocytic 
Melanocytic 
Appendageal 
Haematolymphoid 
Soft tissue 
Neural 
52
57
87
1
37
4
21.85
23.95
36.55
0.42
15.55
1.68
20
9
70
1
43
0
13.99
6.29
48.95
0.7
30.07
0
14
3
20
3
36
0
18.42
3.95
26.32
3.95
47.37
0
55
2
7
0
29
1
58.51
2.13
7.45
0
30.85
1.06
0.001
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neural BSLs. The lesion diameter of the melanocytic BSLs 
was significantly lower compared with that of the main 
groups of appendageal and soft tissue BSLs. The lesion 
diameter of the keratinocytic BSLs and soft tissue BSLs 
were significantly lower than that of the appendageal BSLs 
(Table 4).
DISCUSSION
The epidemiological studies on skin diseases have 
reported the rates of BSL and MSL at 4.5-12% and 1.5-
6%, respectively (Bertanha et al. 2006; Furue et al. 2011; 
Mohammedamin et al. 2006). In general, the ratio of BSLs 
to the malignant ones is 1.5 or 4.5 (Bertanha et al. 2006; 
Furue et al. 2011; Kartal et al. 2015; Mohammedamin et al. 
2006). Recent studies have reported a tendency of PSLs to 
increase over the last years, with rates 1.82%-4% found in 
large-scale epidemiological studies (Bas et al. 2014; Choi 
et al. 2016; Kim et al. 2010). 
 In various studies, BSLs were mostly seen in women 
(53.7%-63.2%) (Bertanha et al. 2016; Sinikumpu et al. 
2014). In the present study, 56% (n = 310) of all BSLs 
were found in males, and 47.7% (n = 241) were found in 
females. In several epidemiological studies conducted in 
various countries, the most common type of BSL in females 
and males is keratinocytic BSLs (Furue et al. 2011; Kartal 
et al. 2015; Mohammedamin et al. 2006). In the present 
study, appendageal BSLs was the most common type found 
in females and males.
 In various studies, 55%-60% of BSLs were seen in 
the 15-59 age group (Furue et al. 2011; Sinikumpu et al. 
2014). In the present study, 79.85% (n = 440) of all BSLs 
were seen in the 15–59 age group. The most common BSL 
type among children, adolescents, middle-aged, and elderly 
people has been reported to be keratinocytic BSL based on 
epidemiological studies on skin diseases (Kyriakis et al. 
2012; Sinikumpu et al. 2014). In the present study, the most 
common types of BSL in the 0-14 and 15-59 age groups are 
keratinocytic and appendageal BSLs, respectively; overall, 
keratinocytic and appendageal BSLs are the most common 
BSL types.
 In some studies, BSLs have been reported to be more 
common in the head and neck regions, and in some studies 
they have been reported to be more common in the truncal 
region (Gogi & Ramanujam 2013; Pujani et al. 2016). In 
the present study, 43.19% (n = 238) of BSLs were localized 
in the head and neck region. The BSL diameters reported in 
the studies are usually less than 25 mm (Furue et al. 2011; 
Pujani et al. 2016). In the present study, the lesion diameter 
of BSLs was between 1 and 70 mm, and the mean was 14.1 
mm. Appendageal BSLs were found to be the largest lesions 
with a mean diameter of 17.33 mm. BSLs reported in the 
literature are generally singular (Ferrándiz et al. 2017; 
Pujani et al. 2016). In the present study, 82.57% (n = 455) 
of BSLs were single lesions.
 BSLs can accompany some systemic diseases (Nguyen 
& Zuniga 2013). An underlying systemic disease should 
be investigated especially in the presence of multiple 
lesions. In the presence of multiple seborrheic keratosis 
(SK); trichilemmoma; or cystic sebaceous tumors (CSTs), 
malignancies of the internal organs, such as the stomach, 
colon, or the pancreas, should be suspected (Gogi & 
Ramanujam 2013; Kanitakis 2010; Luba et al. 2003). The 
incidences of CSTs, keratoacanthoma, and sebaceoma 
increase in Muir–Torre syndrome; the incidences of 
hemangioma, lipoma, and trichilemmoma increase in 
Cowden’s disease; the incidence of CST increases in 
Gardner syndrome (Gogi & Ramanujam 2013; Luba et al. 
2003). However, we did not observe any of these conditions 
in the present study.
 Several studies have demonstrated that some BSLs 
may develop into malignant tumors (Lee 2010). It has 
TABLE 4. The relationship between number of lesions and diameter of benign skin lesions
Benign skin lesions
Number of lesions
Chi-square TestSingle Multiple
n % n % p
Keratinocytic 
Melanocytic 
Appendageal 
Hematolymphoid 
Soft tissue 
Neural 
106
48
163
5
128
5
23.3
10.55
35.82
1.1
28.13
1.1
35
23
21
0
17
0
36.46
23.96
21.88
0
17.71
0
0.001
Lesion diameter (mm) Kruskal–Wallis Test
n Mean Min Max SD p
Keratinocytic 
Melanocytic
Appendageal
Hematolymphoid
Soft tissue 
Neural
141
71
184
5
145
5
11.26
8.73
17.33
9.2
15.66
15.8
1
2
3
3
2
6
35
50
55
16
70
35
7.19
6.2
9.68
5.81
13.22
11.92
0.001
2698 
been reported that basal cell carcinoma may develop 
from SK; squamous cell carcinoma may develop from 
verruca vulgaris or keratoacanthoma lesions; melanoma 
may develop from melanocytic nevi (Gogi & Ramanujam 
2013). None of these conditions were found in the present 
study. Malignant lesions can be misdiagnosed as benign 
(Lee 2010). In the present study, although the physical 
examination findings of nine patients were like BSL, the 
pathological examination confirmed MSL. These patients 
accounted for 1.6% of MSL patients. For this reason, biopsy 
should be taken to confirm the diagnosis (Ferrándiz et al. 
2017).
 Several studies recommend fine-needle aspiration, 
core, or excisional biopsy to be performed, allowing for a 
definite diagnosis to be made so that the tumor structure 
and histological type can be identified, and its grade 
can be determined (Ferrándiz et al. 2017; Hwang et al. 
2016). Studies report that the core biopsy is superior to 
the fine-needle aspiration biopsy and excisional biopsy is 
superior to core biopsy in terms of sensitivity, specificity, 
predictive value, and accuracy (Wakely & Kneisl 2000; 
Woon & Serpell 2008). It has been reported that the overall 
diagnostic accuracy of the excisional biopsy may be as 
high as 98% (Kasraeian et al. 2010). 
 In the present study, an excisional biopsy was 
performed that preserved the healthy margins (>1 mm) for 
all lesions prediagnosed as BSL. The diagnostic accuracy 
was found to be 100%. Several studies have reported that 
there might be recurrences in the lesions after the excisional 
biopsies at varying rates ranging from 2%–5% (Layfield 
et al. 2014). The recurrence rate after excisional biopsy 
was 2.3% in the present study, and surgical excision was 
repeated in these patients (Kasraeian et al. 2010; Layfield et 
al. 2014). Excisional biopsy was successful in the diagnosis 
and treatment of patients. 
CONCLUSION
In the present study, we evaluated the clinical profile and 
different types of BSLs in terms of age, gender, and area 
distribution. Some BSLs may be associated with systemic 
diseases or malignancies. BSLs may also develop into a 
malignant tumor. Therefore, clinicians should follow a 
systematic approach to BSLs. Sometimes, the diagnosis 
of skin neoplasias cannot be made based on their clinical 
characteristics solely. Hence, a pathological examination 
should be performed. As in the present study, excisional 
biopsy can be performed successfully for both diagnosis 
and treatment.
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